Tag: Prescription Drugs
ACEIs/ARBs Not Linked to Severity or Mortality of COVID-19
Percentage of patients with hypertension taking ACEIs/ARBs similar for survivors, nonsurvivors
Expert Panel: There Are No Proven Drug Treatments for COVID-19
Whenever possible, drugs should be given to COVID-19 patients as part of a clinical trial
Hydroxychloroquine Seems Not to Cut Ventilator Use in COVID-19
Risk for death from any cause higher for HC alone, similar for HC+AZ compared with no HC
Physicians Report Low Interest in Opioid Use Disorder Meds
Few PCPs report obtaining buprenorphine waiver orprescribing buprenorphine, naltrexone for OUD
IDSA Issues Rapid Guidelines for Treatment of COVID-19
Expert panel urges that treatments for COVID-19 be given in the context of clinical trials
Novel Agent Promising for the Treatment of Schizophrenia
Reduction in PANSS total score greater for non-D2-receptor-binding drug SEP-363856 versus placebo
Preoperative Metformin Tied to Better Surgical Outcomes
Risks for postop mortality, readmission down among adults with T2DM who received preop metformin
CDC: Overall Prevalence of Self-Reported Hypertension 32.4 Percent
Unadjusted prevalence of self-reported antihypertensive meds use 76.0 percent for those with HTN
Remdesivir May Improve Oxygen-Support Class in Severe COVID-19
Oxygen-support class improved in 68 percent of patients receiving compassionate use of remdesivir
Physicians Report Expanding Use of Off-Label COVID-19 Treatments
Hydroxychloroquine usage increasing rapidly, although plasma from recovered patients perceived as more effective
